InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Wentworth Kerry, Directeur Réglementaire. Director active across 1 company, notably Flexion Therapeutics Inc. Cumulatively, 6 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 21 June 2021. The latest transaction was disclosed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
140,843 shares@ US$8.5048.8% of flowCommon StockSEC:0001209191-21-065709
140,843 shares@ US$8.5048.8% of flowCommon StockSEC:0001209191-21-065709:0
3,944 shares@ US$6.451.0% of flowCommon StockSEC:0001209191-21-047504
3,944 shares@ US$6.451.0% of flowCommon StockSEC:0001209191-21-047504:0
539 shares@ US$7.780.2% of flowCommon StockSEC:0001209191-21-043523
539 shares@ US$7.780.2% of flowCommon StockSEC:0001209191-21-043523:0
6 of 6 declarations
About Wentworth Kerry
Kerry Wentworth is the Chief Regulatory Officer at Flexion Therapeutics Inc. He is responsible for the company's regulatory compliance, ensuring that operations meet current standards. His role is essential for the reputation and compliance of Flexion Therapeutics Inc.
